DEPAKOTE

This brand name is authorized in Brazil, France, United Kingdom, United States

Active ingredients

The drug DEPAKOTE contains one active pharmaceutical ingredient (API):

1 Divalproex sodium UNII 644VL95AO6 - DIVALPROEX SODIUM

Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA. Read about Valproic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DEPAKOTE Delayed-release tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR
DEPAKOTE SPRINKLES Capsule	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AX	Other antipsychotics	N Nervous system → N05 Psycholeptics → N05A Antipsychotics
Discover more medicines within N05AX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 500202503110318, 500202504117316, 500202601112315, 500202603115311, 500209002117317, 500209003113315, 500209004111316, 500209005116311, 500216120035503, 500216120035603
Country: FR	Base de données publique des médicaments	Identifier(s): 60797287, 66508736
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 364429, 364431, 374027, 378888, 380773, 381277, 381279, 381280
Country: US	FDA, National Drug Code	Identifier(s): 0074-3826, 0074-6114, 0074-6212, 0074-6214, 0074-6215, 0074-7126, 70518-1454, 70518-1456, 70518-1758, 70518-1759